The THYBLATE™ electrodes are CE-certified and indicated for the treatment of benign thyroid nodules (cystic and non-cystic), goiters, AFTN, and malignant tumors. The THYBLATE™ electrodes are FDA 510(k) cleared for percutaneous and intraoperative coagulation and ablation of tissue. While the THYBLATE™ Thyroid RFA Procedure may offer substantial benefits to many patients, it is not universally applicable, and individual outcomes may vary. Please contact your medical professional for specific advice regarding the potential benefits, risks, and suitability of this treatment in your specific case.
IMPORTANT SAFETY INFORMATION
LEGAL DISCLAIMER
The Site cannot and does not provide medical/health advice. The medical/health information here is for general informational and educational purposes only and is not a substitute for professional advice. The content on this Site is not intended for sale or promotion in jurisdictions where such activities are restricted. The imagery used on this Site is for illustrative purposes only and should not be interpreted as an endorsement or representation of typical patient outcomes. For more details about information provided on this Site, please click here.
FULL SOURCE LIST
To find the full list of sources used on this website, please click here.